Somerville Kurt F Novartis Ag Transaction History

Somerville Kurt F

$578 Million
Q4 2024

A detailed history of Somerville Kurt F transactions in Novartis Ag stock. As of the latest transaction made, Somerville Kurt F holds 17,128 shares of NVS stock, worth $1.89 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

17,128

Previous 25,108 31.78%

Holding current value

$1.89 Million

Previous $2.89 Million 42.29%

% of portfolio

0.29%

Previous 0.48%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$96.78 - $117.18 $772,304 - $935,096	-7,980 Reduced 31.78%	17,128 $1.67 Million
Q3 2024 Nov 12, 2024	SELL	$106.13 - $120.89 $649,197 - $739,484	-6,117 Reduced 19.59%	25,108 $2.89 Million
Q2 2024 Aug 12, 2024	SELL	$92.57 - $107.37 $2.06 Million - $2.39 Million	-22,259 Reduced 41.62%	31,225 $3.32 Million
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $4.04 Million - $4.6 Million	-42,365 Reduced 44.2%	53,484 $5.17 Million
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $2.63 Million - $2.89 Million	-28,508 Reduced 22.92%	95,849 $9.68 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $435,094 - $482,862	-4,593 Reduced 3.56%	124,357 $12.7 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $1.43 Million - $1.62 Million	-15,440 Reduced 10.69%	128,950 $13 Million
Q1 2023 May 10, 2023	BUY	$80.03 - $92.81 $62,823 - $72,855	785 Added 0.55%	144,390 $13.3 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $777,787 - $952,493	-10,295 Reduced 6.69%	143,605 $13 Million
Q3 2022 Nov 08, 2022	SELL	$74.61 - $87.26 $86,174 - $100,785	-1,155 Reduced 0.74%	153,900 $11.7 Million
Q2 2022 Jul 19, 2022	SELL	$80.52 - $93.75 $519,917 - $605,343	-6,457 Reduced 4.0%	155,055 $13.1 Million
Q1 2022 May 17, 2022	SELL	$80.11 - $90.62 $1.05 Million - $1.19 Million	-13,140 Reduced 7.52%	161,512 $14.2 Million
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $417,149 - $461,272	-5,234 Reduced 2.91%	174,652 $15.3 Million
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $60,353 - $70,213	-738 Reduced 0.41%	179,886 $14.7 Million
Q2 2021 Aug 09, 2021	SELL	$85.24 - $94.15 $53,701 - $59,314	-630 Reduced 0.35%	180,624 $16.5 Million
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $181,195 - $213,679	2,170 Added 1.21%	181,254 $15.5 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $132,719 - $160,531	1,700 Added 0.96%	179,084 $16.9 Million
Q3 2020 Oct 28, 2020	BUY	$82.14 - $91.0 $68,011 - $75,348	828 Added 0.47%	177,384 $15.4 Million
Q2 2020 Jul 28, 2020	BUY	$80.93 - $91.1 $14,972 - $16,853	185 Added 0.1%	176,556 $15.4 Million
Q1 2020 May 07, 2020	BUY	$70.67 - $99.01 $285,153 - $399,505	4,035 Added 2.34%	176,371 $14.5 Million
Q4 2019 Jan 15, 2020	SELL	$84.35 - $95.37 $132,598 - $149,921	-1,572 Reduced 0.9%	172,336 $16.3 Million
Q3 2019 Nov 06, 2019	SELL	$85.54 - $94.26 $32,163 - $35,441	-376 Reduced 0.22%	173,908 $15.1 Million
Q2 2019 Jul 24, 2019	SELL	$75.4 - $92.8 $393,437 - $484,230	-5,218 Reduced 2.91%	174,284 $15.9 Million
Q1 2019 May 01, 2019	BUY	$75.32 - $86.15 $16,645 - $19,039	221 Added 0.12%	179,502 $17.3 Million
Q4 2018 Jan 24, 2019	BUY	$73.66 - $82.02 $72,186 - $80,379	980 Added 0.55%	179,281 $15.4 Million
Q3 2018 Oct 15, 2018	BUY	$66.94 - $77.43 $206,576 - $238,948	3,086 Added 1.76%	178,301 $15.4 Million
Q2 2018 Jul 30, 2018	BUY	$64.91 - $73.36 $121,641 - $137,476	1,874 Added 1.08%	175,215 $13.2 Million
Q1 2018 Apr 24, 2018	SELL	$70.39 - $84.15 $525,179 - $627,843	-7,461 Reduced 4.13%	173,341 $14 Million
Q4 2017 Feb 02, 2018	SELL	$72.33 - $77.64 $1.04 Million - $1.11 Million	-14,342 Reduced 7.35%	180,802 $15.2 Million
Q3 2017 Oct 26, 2017	BUY	$74.14 - $77.27 $14.5 Million - $15.1 Million	195,144	195,144 $16.8 Million

Others Institutions Holding NVS

# of Institutions

1,477

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

News

Stay updated on Somerville Kurt F with notifications on news.

Account

Somerville Kurt F Novartis Ag Transaction History